Search
Search Results
##search.searchResults.foundPlural##
-
HIV INFECTION, ANTIRETROVIRAL THERAPY AND CARDIOVASCULAR RISK
1781PDF: 787HTML: 3587 -
FDG-PET SCAN: A NEW PARADIGM FOR FOLLICULAR LYMPHOMA MANAGEMENT.
3279PDF: 1227HTML: 2186 -
THE SPECTRUM OF GENETIC DEFECTS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2207PDF: 870HTML: 1989Fig 1 Rossi: 170 -
LYON-UNIVERSITY HOSPITAL EXPERIENCE WITH GEMTUZUMAB OZOGAMICIN THERAPY IN ACUTE MYELOID LEUKEMIA: A ‘REAL-LIFE’ STUDY Gemtuzumab ozogamicin in AML
1632PDF: 1149HTML: 235 -
HEMATOPOIETIC CELL TRANSPLANTATION FOR OLDER PATIENTS WITH MDS
1978PDF: 750HTML: 3105 -
REGULATORY T-CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2282PDF: 960HTML: 7609Untitled: 269Fig2: 179Fig3: 162Fig4: 175 -
IS IT POSSIBLE TO PREDICT TUMOR PROGRESSION THROUGH GENOMIC CHARACTERIZATION OF MONOCLONAL GAMMOPATHY AND SMOLDERING MULTIPLE MYELOMA? MONOCLONAL GAMMOPATHY AND SMOLDERING MULTIPLE MYELOMA
2519PDF: 1113HTML: 129 -
MILD BLEEDERS: DIAGNOSIS IS ELUSIVE IN LARGE NUMBER OF PATIENTS
3290PDF: 713HTML: 703Figure 1 Distribution of the various causes of mild bleeding (in %) in males and females: 175Figure 2 Age and Sex distribution of patients with Bleeding disorders- Unclassified: 174Table : Distribution of the sites of bleeding and their causes: 173 -
Microangiopathic Anemia of Acute Brucellosis – is it a True TTP?
1148PDF: 778HTML: 1760 -
PRACTICAL RECOMMENDATIONS FOR THE MANAGEMENT OF PATIENTS WITH ITP DURING THE COVID-19 PANDEMIC Recommendation for ITP management during COVID
2404PDF: 906HTML: 505 -
CURRENT KNOWLEDGE ON HIV-ASSOCIATED PLASMABLASTIC LYMPHOMA
2554PDF: 1591HTML: 2345Table1: 187 -
IMATINIB IN CHRONIC MYELOID LEUKEMIA: AN OVERVIEW
4631PDF: 2791HTML: 2263 -
TOLL-LIKE RECEPTORS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2539PDF: 856HTML: 17457Fig1 Caligaris: 162Fig.2 Caliga: 195 -
Treating relapsed/refractory acute myeloid leukemia with chidamide, fludarabine, cytarabine and granulocyte-colony stimulating factor with subsequent bridging to myeloablative allogeneic hematopoietic stem cell transplantation Treating relapsed/refractory acute myeloid leukemia with chidamide, fludarabine, cytarabine and G-CSF
1737PDF: 558HTML: 269 -
Respiratory function in pediatric African SCA patients underwent bone marrow transplantation
2101PDF: 750HTML: 1027Spirometry in SCA patients before transplant: 197Spirometry in SCA patients post transplant: 177 -
LYMPHOCYTES IN PATIENTS WITH CHRONIC ACTIVE EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1 EXPRESSION AND A PREVAILING TH2 IMMUNE RESPONSE. EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1
2598PDF: 1064HTML: 100 -
INFECTIOUS COMPLICATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA
3248PDF: 1332HTML: 2618 -
EFFICACY OF VENETOCLAX COMBINED WITH AZACITIDINE IN ELDERLY PATIENTS WITH RELAPSED ACUTE MYELOID LEUKEMIA
1432PDF: 740Suppl. Files: 313Html: 127 -
SOCIAL IMPLICATIONS OF MALARIA AND THEIR RELATIONSHIPS WITH POVERTY
6008PDF: 3215HTML: 9002Figure Malaria Ricci: 220 -
LETERMOVIR PRIMARY CYTOMEGALOVIRUS PROPHYLAXIS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS: COULD INFECTION AND DISEASE NO LONGER BE A SIGNIFICANT PROBLEM? Letermovir and Cytomegalovirus Prophylaxis in HSCT
1258PDF: 997HTML: 112 -
THE HISTORY OF DEFERIPRONE (L1) AND THE COMPLETE TREATMENT OF IRON OVERLOAD IN THALASSAEMIA The history and roles of deferiprone
2344PDF: 1569HTML: 599 -
NOVEL AGENTS AND EMERGING STRATEGIES FOR TARGETING THE B-CELL RECEPTOR PATHWAY IN CLL
2457PDF: 830HTML: 8802Efremov 1: 216Efremov 2: 177







